MTH insider files Form 144 to sell 6,518 shares via Merrill Lynch

Rhea-AI Filing Summary

Meritage Homes Corporation (MTH) filed a Form 144 notifying a proposed sale of 6,518 common shares through Merrill Lynch on 08/12/2025, with an aggregate market value of $466,400.54. The filing lists 71,156,138 shares outstanding. The shares were acquired on 08/10/2022 as vested restricted shares from Meritage Homes and were received as a stock bonus. The filer reports no securities sold in the past three months and affirms they are not aware of any undisclosed material adverse information. Broker name and address are provided in the notice.

Insights

Financial Analyst

TL;DR: Form 144 discloses a planned sale of 6,518 MTH shares ($466,400.54); the amount disclosed appears unlikely to be market-moving.

The filing specifies the planned disposition, the broker (Merrill Lynch), the proposed sale date (08/12/2025), and the acquisition details (vested restricted shares acquired 08/10/2022 as a stock bonus). The filer reports no sales in the prior three months, which limits immediate patterns of insider selling disclosed in the filing. From a financial perspective, the notice documents intent to sell but provides no new operational or earnings information that would materially change valuation models.

Corporate Governance Expert

TL;DR: The filing contains the required Rule 144 disclosures and an attestation regarding undisclosed material information; documentation appears procedurally complete.

The Form 144 includes statutory elements: identity of broker, number of shares, aggregate market value, acquisition method and date, and the filer’s representation regarding material nonpublic information. It also references Rule 10b5-1 planning language. There are no reported prior sales in the three-month window. The notice reflects standard compliance with transfer and reporting rules rather than any governance red flags.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 2555 E. CAMELBACK RD SUITE 900 PHOENIX AZ 85016	6518	466400.54	71156138	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/10/2022	VESTED RESTRICTED SHARES	MERITAGE HOMES CORPORATION			6518	08/10/2022	STOCK BONUS

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Meritage Homes (MTH) Form 144 disclose?

The filing discloses a proposed sale of 6,518 common shares through Merrill Lynch on 08/12/2025 with an aggregate market value of $466,400.54.

How and when were the shares acquired?

The shares were acquired on 08/10/2022 as vested restricted shares from Meritage Homes, with the consideration listed as a stock bonus.

Were there any sales by the filer in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Who is the broker handling the proposed sale?

The broker listed is Merrill Lynch, 2555 E. Camelback Rd Suite 900, Phoenix, AZ 85016.

What attestation does the filer make regarding undisclosed information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 language if applicable.